Display options
Cite
Fallah E, Arman S, Najafi M, et al. Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents. Iran J Child Neurol. 2016;10(2):16-25
Fallah, E., Arman, S., Najafi, M., & Shayegh, B. (2016). Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents. Iranian journal of child neurology, 10(2), 16-25.
Fallah, Elham, et al. "Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents." Iranian journal of child neurology vol. 10,2 (2016): 16-25.
Fallah E, Arman S, Najafi M, Shayegh B. Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents. Iran J Child Neurol. 2016;10(2):16-25. PMID: 27247580; PMCID: PMC4885151.
Copy Download .nbib Format: NLM
Share it on

Iran J Child Neurol. 2016;10(2):16-25.

Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents.

Iranian journal of child neurology

Elham Fallah, Sorror Arman, Mostafa Najafi, Bahar Shayegh

Affiliations

  1. Child Psychiatry Department, Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  2. Child Psychiatrist, Isfahan university of medical sciences, Isfahan, Iran.
  3. Department of Psychology, Islamic Azad University, Sharekord Branch, Sharekord, Iran.

PMID: 27247580 PMCID: PMC4885151

Abstract

OBJECTIVE: Many studies have supported the role of protein kinase C (PKC) inhibitors in the physiopathology and treatment of bipolar disorder in adults. Tamoxifen is one of the drugs with the effect of PKC inhibition. This study aimed to determine the effect of tamoxifen on the rate of improvement mania symptoms in the sample of children and adolescents with acute mania.

MATERIALS & METHODS: In this randomized, placebo-controlled clinical trial study, registered in www.irct.ir with the code of IRCT201410126418N3, overall 44 patients with bipolar disorder with acute manic episode were randomly assigned into treatment and control groups. The serum levels of lithium and tamoxifen among the participants in the treatment groups were 0.8 -1.1 mg and 20-40 mg per day respectively. Serum level of lithium among participants in the control group was similar. The main comparisons were made based on the Young Mania Rating Scale (YMRS) and Children Depression Inventory (CDI) scores of the participants at baseline and at the end of each study week. The pharmacological side effects of serum level of lithium were examined weekly. Analysis of Covariance(ANCOVA) test was used for the statistical analysis.

RESULTS: There was no difference in the baseline score of YMRS and CDI in the treatment and control groups while a statistical significant difference (P < 0.05) in these scores was found between and within the groups.

CONCLUSION: The addition of tamoxifen to lithium causes a significant difference in reducing the symptoms of mania and depression in the treatment group compared to the control group.

Keywords: Children; Lithium; Mania; Protein Kinase C; Tamoxifen

References

  1. Arch Gen Psychiatry. 2000 Jan;57(1):95-7 - PubMed
  2. BMC Psychiatry. 2006 Mar 15;6:10 - PubMed
  3. Neuropsychobiology. 2007;55(3-4):123-31 - PubMed
  4. J Pediatr Hematol Oncol. 2000 May-Jun;22(3):247-51 - PubMed
  5. Biol Psychiatry. 1993 Apr 1;33(7):520-5 - PubMed
  6. Acta Psychiatr Scand Suppl. 2007;(434):27-34 - PubMed
  7. Biol Psychiatry. 1999 Nov 15;46(10):1328-51 - PubMed
  8. J Pediatr. 2003 Jul;143(1):60-6 - PubMed
  9. Bipolar Disord. 2007 Sep;9(6):561-70 - PubMed
  10. Psychoneuroendocrinology. 2006 May;31(4):543-7 - PubMed
  11. Psychosomatics. 2007 May-Jun;48(3):205-10 - PubMed
  12. Neurosci Biobehav Rev. 2007;31(6):825-31 - PubMed
  13. J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6 - PubMed
  14. J Pediatr. 2004 Jul;145(1):71-6 - PubMed
  15. Biol Psychiatry. 1996 Oct 1;40(7):568-75 - PubMed
  16. Neuropharmacology. 1992 Dec;31(12):1201-10 - PubMed
  17. Curr Psychiatry Rep. 2007 Dec;9(6):521-8 - PubMed
  18. Psychopharmacology (Berl). 2007 Mar;191(1):39-54 - PubMed
  19. J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):539-47 - PubMed
  20. J Psychopharmacol. 2009 May;23(3):334-7 - PubMed
  21. J Cell Biol. 2005 Sep 26;170(7):1147-58 - PubMed
  22. J Affect Disord. 2003 Nov;77(2):179-90 - PubMed
  23. Neuron. 2005 Oct 6;48(1):77-90 - PubMed
  24. Arch Gen Psychiatry. 2008 Mar;65(3):255-63 - PubMed
  25. Neuropharmacology. 1992 Dec;31(12):1211-22 - PubMed
  26. Mol Psychiatry. 2002;7 Suppl 1:S1-7 - PubMed
  27. Brain Res Mol Brain Res. 1993 Dec;20(4):289-98 - PubMed
  28. J Affect Disord. 2011 Mar;129(1-3):327-31 - PubMed
  29. Breast Cancer Res Treat. 1994;31(1):41-52 - PubMed

Publication Types